Clinical trials sponsored by CHU de Quebec-Universite Laval
8
Recruiting trials
15
Conditions studied
Phase breakdown
Not applicable 8
Conditions studied
Recruiting trials led by CHU de Quebec-Universite Laval
- A Trial Evaluating Toxicity of SBRT and LDRB in Localized Prostate Cancer.
- Biobank on Prematurity, Preeclampsia and Other Pregnancy Complications
- Bone Health After Bariatric Surgery in Patients With Type 2 Diabetes
- Bone and Muscle Health Following Sleeve Gastrectomy in Men, Premenopausal and Postmenopausal Women
- Cognitive Behavioral Therapy for Fear of Cancer Recurrence in Women With BRCA1/2 Gene
- Non-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions (52.5 Gy/20) for Recurrent Prostate Cancer After Surgery.
- Self-questionnaire in Osteoporosis
- Ultra Hypofractionnated Radiotherapy With HDR Brachytherapy Boost.
Common questions
How many trials is CHU de Quebec-Universite Laval recruiting for?
CHU de Quebec-Universite Laval is the lead sponsor of 8 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.